BLASTS 5 PERCENT OR MORE OF BONE MARROW NUCLEATED CELLS

Clinical trials for BLASTS 5 PERCENT OR MORE OF BONE MARROW NUCLEATED CELLS explained in plain language.

Never miss a new study

Get alerted when new BLASTS 5 PERCENT OR MORE OF BONE MARROW NUCLEATED CELLS trials appear

Sign up with your email to follow new studies for BLASTS 5 PERCENT OR MORE OF BONE MARROW NUCLEATED CELLS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Terminated 1

New drug tested for Tough-to-Treat blood cancer

Disease control Terminated

This study tested a new drug called ADCT-602 for adults with a fast-growing blood cancer (B-cell acute lymphoblastic leukemia) that has come back or stopped responding to standard treatments. The main goals were to find a safe and effective dose and to see if the drug could help …

Matched conditions: BLASTS 5 PERCENT OR MORE OF BONE MARROW NUCLEATED CELLS

Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 23, 2026 15:18 UTC

BLASTS 5 PERCENT OR MORE OF BONE MARROW NUCLEATED CELLS

Get alerted when new BLASTS 5 PERCENT OR MORE OF BONE MARROW NUCLEATED CELLS trials appear

New drug tested for Tough-to-Treat blood cancer